BRIEF published on 11/14/2024 at 07:35, 1 month 7 days ago PharmaSGP prévoit une forte croissance de son chiffre d'affaires au cours des 9 premiers mois de 2024 et relève ses prévisions pour l'ensemble de l'année Croissance Des Revenus Stratégie De Marché PharmaSGP Produits Pharmaceutiques En Vente Libre Prévisions Pour 2024
BRIEF published on 11/14/2024 at 07:35, 1 month 7 days ago PharmaSGP Sees Strong Revenue Growth in 9M 2024, Raises Full-Year Forecast Revenue Growth Market Strategy 2024 Forecast PharmaSGP OTC Pharmaceuticals
PRESS RELEASE published on 11/14/2024 at 07:30, 1 month 7 days ago PharmaSGP with strong revenues growth in 9M 2024 – revenues forecast for FY 2024 raised PharmaSGP Holding SE reports strong revenue growth in 9 months of 2024, with preliminary figures showing a 17.0% increase compared to the same period last year. FY 2024 revenue forecast raised Financial Results Revenue Growth Pharmaceuticals Forecast PharmaSGP
BRIEF published on 11/05/2024 at 10:12, 1 month 16 days ago Leadership Transition at PharmaSGP Holding SE: Peter Gerckens to Succeed Natalie Weigand as CEO Company Growth OTC Pharmaceuticals Peter Gerckens Natalie Weigand PharmaSGP Leadership Change
BRIEF published on 11/05/2024 at 10:12, 1 month 16 days ago Transition de direction chez PharmaSGP Holding SE : Peter Gerckens succède à Natalie Weigand au poste de PDG Croissance De L'entreprise Produits Pharmaceutiques En Vente Libre Pierre Gerckens Nathalie Weigand Changement De Direction Chez PharmaSGP
PRESS RELEASE published on 11/05/2024 at 10:07, 1 month 16 days ago CEO change at PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as of January 1, 2025 PharmaSGP Holding SE announces CEO change with Peter Gerckens succeeding Natalie Weigand on January 1, 2025. Smooth transition planned for internal succession Succession Plan CEO Change PharmaSGP Holding SE Peter Gerckens Natalie Weigand
BRIEF published on 11/05/2024 at 10:07, 1 month 16 days ago Leadership Change at PharmaSGP Holding SE: Peter Gerckens Appointed CEO Leadership Transition CEO Change PharmaSGP Holding SE Peter Gerckens Natalie Weigand
BRIEF published on 11/05/2024 at 10:07, 1 month 16 days ago Changement de direction chez PharmaSGP Holding SE : Peter Gerckens nommé PDG Transition De Direction Changement De PDG PharmaSGP Holding SE Pierre Gerckens Nathalie Weigand
PRESS RELEASE published on 11/05/2024 at 10:02, 1 month 16 days ago EQS-Adhoc: PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer PharmaSGP Holding SE appoints Peter Gerckens as new CEO, succeeding Natalie Weigand. Gerckens, currently CCO, will assume the CEO position on January 1, 2025 Supervisory Board PharmaSGP Holding SE CEO Succession Peter Gerckens Natalie Weigand
BRIEF published on 10/01/2024 at 08:20, 2 months 20 days ago PharmaSGP Holding SE acquiert 477 701 actions par le biais d'une offre de rachat Actions Propres Rachat D'actions Réduction De Capital Offre De Rachat PharmaSGP
Published on 12/21/2024 at 01:30, 17 hours 53 minutes ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 53 minutes ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 18 minutes ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 19 hours 53 minutes ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 18 hours 31 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 37 minutes ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 18:00, 1 day 1 hour ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 7 hours 5 minutes ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 7 hours 5 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
